Extended initial course of prednisolone did not improve clinical outcomes in steroid-sensitive nephrotic syndrome

Abstract

Study design: Double-blind, parallel-group, randomised, placebo-controlled trial. Setting and patients: 237 patients with steroid-sensitive idiopathic nephrotic syndrome aged 1–14 years recruited from 125 UK tertiary nephrology centres and district general...